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A B S T R A C T
Purpose: To investigate early predictors (6 months after diagnosis) of refractory epilepsy.
Methods: Study design: prospective cohort study. Inclusion criteria: all consecutive children <14 years
with two or more unprovoked seizures 24 h apart, who were seen at our hospital between 1994 and
2004. Exclusion criteria: patients previously examined in other centres. Deﬁnitions: refractory epilepsy:
failure of >2 drugs plus >1 seizure/month for 18 months. Analysis: risk of developing refractory
epilepsy was calculated using Kaplan–Meier survival curves. Univariable and multivariable analyses of
potential predictors of developing refractory epilepsy were carried out using Cox proportional hazards
model.
Results: 343 patients were included. Mean age at diagnosis was 4.8 years (3.8 SD). Mean follow-up
period was 76.2 (35.2 SD) months (range 24–139). Risk of developing refractory epilepsy was 8% at 6 years.
Risk for idiopathic syndromeswas 2%. For non-idiopathic syndromes the riskwas 38% for patients with age at
onset <1 year plus >1 seizure during the ﬁrst 6 months after diagnosis, 9% for age at onset <1 year plus 0–1
seizures during the ﬁrst 6months, 22% for age at onset1 year plus>1 seizures during the ﬁrst 6months and
3% for age at onset 1 year plus 0–1 seizures during the ﬁrst 6 months.
Conclusion: Risk of developing refractory epilepsy is very low in idiopathic syndromes. For the rest of
patients, a simple model comprising three variables allows more accurate prediction of risk of
refractoriness.
 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Most children with epilepsy do well on antiepileptic treatment.
However, some patients respond poorly to antiepileptic drugs
(AEDs) and develop refractory (intractable) epilepsy. Early
identiﬁcation of children at risk of developing refractory epilepsy
is important for parents’ counselling and consideration of
alternative treatments. Some studies investigating prognostic
factors of refractory epilepsy have been published, but most of
them have a case–control design.1–9 This type of study does not
allow estimation of the risk of developing refractory epilepsy in
patients with a given risk factor. Only three prospective cohort
studies are available.2,7,9 One of them did not include patients
younger than 2 years old7, a group of children particularly at risk of
developing refractory epilepsy, and the other one used broad
criteria for deﬁning refractory epilepsy.9 Therefore, a prospective* Corresponding author at: Unidad de Neurologı´a Pedia´trica, Servicio de
Pediatrı´a, Hospital Torreca´rdenas, Almerı´a, Paraje de Torreca´rdenas s/n, Almerı´a,
Spain. Fax: +34 950016856.
E-mail addresses: jramoslizana@telefonica.net (J. Ramos-Lizana),
paguileralopez@gmail.com (P. Aguilera-Lo´pez), javieraguirrerodriguez@orange.es
(J. Aguirre-Rodrı´guez), elicassinello@hotmail.com (E. Cassinello-Garcı´a).
1059-1311/$ – see front matter  2009 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2009.02.006cohort study is needed. The objective of the present work is to
investigate the value of potential prognostic factors identiﬁable at
6 months from diagnosis in a prospectively followed cohort of
children younger than 14 years old with recent-onset epilepsy.
2. Methods
2.1. Deﬁnitions and classiﬁcation criteria
Seizures were considered unprovoked when they occurred in
the absence of any known proximate precipitant. More than one
seizure within a period of 24 h was considered to be a single
seizure (multiple seizure). Epilepsy was deﬁned as the occurrence
of two or more unprovoked seizures. Status epilepticuswas deﬁned
as a seizure lastingmore than 30 min or recurrent seizures lasting a
total of more than 30 min without the patient fully regaining
consciousness. The type of seizure was classiﬁed according to the
1981 ILAE criteria.10 We considered that a patient had various
seizure types when he/she had both partial and generalized
seizures, various types of partial seizures (for example simple
partial and secondarily generalized seizures) or various types of
generalized seizures (for example absences and generalized tonic–
clonic seizures). Epilepsies were classiﬁed according to theirvier Ltd. All rights reserved.
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following the ILAE criteria.11 In particular, epilepsies were
classiﬁed as remote symptomatic when they occurred in a patient
with a history of a static encephalopathy of pre- or perinatal origin
or a prior neurological insult such as central nervous system
infection, stroke or signiﬁcant head trauma.11 Classiﬁcation of
patients by epileptic syndrome was also performed according to
the ILAE revised 1989 classiﬁcation.12 Into the category ‘‘without
unequivocal partial or generalized seizures’’ we classiﬁed all
patients with apparently generalized tonic–clonic seizures and a
normal EEG. Two new syndromes, not included in this classiﬁca-
tion, were also diagnosed: benign infantile seizures and early-
onset benign childhood occipital epilepsy (Panayiotopoulos type).
EEGs were classiﬁed as normal or abnormal; the latter category
includes both epileptiform (focal or generalized spike-waves) and
nonepileptiform (focal or generalized slowing) abnormalities. A
family history of unprovoked seizures was deﬁned as seizures
occurring in a ﬁrst-degree relative (parent or sibling). Neuroima-
ging was classiﬁed as abnormal only when the observed
abnormality was considered the cause of epilepsy. Global
developmental delay was deﬁned as a developmental quotient
below 70% and mental retardation as an intelligence quotient
below 70. When formal intelligence tests were not available,
intelligence was clinically assessed. Motor deﬁcit was considered
as present if there was hemiplegia, quadriplegia or diplegia.
Refractory epilepsy was deﬁned as failure, due to lack of seizure
control, of more than 2 AED at maximum tolerated doses, with an
average of more than 1 seizure per month for 18 months and no
more than 3 consecutive months seizure-free during this interval.2
Drugs withdrawn due to intolerable adverse effects in patients
without recurrences were not taken into account.
2.1.1. Cohort selection
Torreca´rdenas Hospital is the reference hospital of the province
of Almerı´a (Spain). The only EEG laboratory and paediatric
neurology unit in the province are located in this hospital.
Between June 1, 1994 and December 31, 2004 all patients aged less
than 14 years who were consecutively seen at our institution for
two or more unprovoked seizures were enrolled in a prospective
study. Patients with seizures limited to the neonatal period, inborn
errors of metabolism, neurodegenerative disorders, children
already on antiepileptic treatment and those who had previously
been examined in other centres were excluded. Consequently, all
patients were directly referred by primary care paediatricians or
were ﬁrst seen in the emergency department of our hospital. The
study was approved by the ethical committee of the hospital and
informed consent was obtained to participate in it.
2.2. Initial evaluation
For every patient, family and medical history were taken, a
physical and neurological examination was performed and a
standard EEG was obtained at diagnosis of epilepsy. When the
standard EEG was normal, a sleep record was performed.
Computed tomography or magnetic resonance imaging was
performed at least in the cases with abnormal ﬁndings in the
neurological examination, partial seizures, focal abnormalities on
the EEG (except in the case of benign childhood epilepsy with
centro-temporal spikes) or West syndrome.
2.2.1. Follow-up
All patients were followed through personal interviews at
regular intervals until December 31, 2006 (to allow for a minimum
of 2 years’ follow-up) or until they attain a remission of 3 years
without AEDs (i.e. 3 years without either relapses or treatment).
Patients in remission were thereafter contacted by telephone untila follow-up of 5 years without antiepileptic treatment was
completed. Then, patients were instructed to contact us if a
relapse occurred. Otherwise the patient was considered in
remission.
2.2.2. Predictors of refractoriness
The following variables, all measured at 6 months of follow-up,
were explored: sex, age at onset of epilepsy in years, prior febrile
seizures, prior neonatal seizures, family history of epilepsy in ﬁrst-
degree relatives, aetiology, global developmental delay/mental
retardation, motor deﬁcit, abnormal neuroimaging (compared to
normal or not done), status epilepticus at diagnosis, multiple
seizures at diagnosis, abnormal EEG, various seizures types, West
syndrome, number of seizures before diagnosis and number of
seizures during the ﬁrst 6 months after diagnosis. For treated
patients the date of diagnosis was the same as the date of
treatment onset. For patients with epilepsies characterised by a
high frequency of seizures, such as absence epilepsy or West
syndrome, seizures during the initial medication titration phase
were not considered as recurrences.
2.2.3. Analysis
Risk of developing refractory epilepsy was calculated using
Kaplan–Meier survival curves. Patients entered the study on the
date of diagnosis of epilepsy. The event under study was fulﬁlling
the criteria of refractory epilepsy. Cases were considered censored
if, at the end of the study, the event under observation had not
occurred or if contact with the patient was lost. We carried out
univariable and multivariable analyses of potential predictors of
developing refractory epilepsy using Cox proportional hazards
model. Calculations were performed by means of statistical
software SPSS for Windows, version 15.0. The level of statistical
signiﬁcance was established at p < 0.05.
3. Results
3.1. General features of the sample
Three hundred and ﬁfty-three children were enrolled in the
study. 8 patients were lost to follow-up before completing a
minimum follow-up period of 2 years and 2 children died within 2
years of diagnosis. Therefore, 343 patients were followed-up for
more than 2 years and they constitute the sample of this study.
Thereafter, another 6 patientswere lost to follow-up and 4 children
died. Overall, we lost contact with only 4% (8 + 6) cases from the
initial sample. Mean age at diagnosis was 4.8 (3.8 SD) years. 68
(20%) of the children were younger than 1 year of age at diagnosis of
epilepsy, 236 (69%) between 1 and 9 years old and 39 (11%) were 10
years of age or older. 191 (56%) were male and 152 (44%) female. 34
(9.9%) patients were not treated. Mean follow-up period was 76.2
(35.2 SD) months (range 24–139). Of the 343 children, 249 (73%)
were followed for more than 4 years, 168 (49%) for more than 6 years
and 104 (30%) for more than 8 years.
3.1.1. Overall risk of developing refractory epilepsy
Thirty out of 343 patients (8.7%) met the criteria of refractory
epilepsy. The Kaplan–Meier estimate of the risk of developing
refractory epilepsy was 5% (95% CI: 3–7), 7% (95% CI: 4–10), 8%
(95% CI: 5–11), 11% (95% CI: 7–15) and 12% (95% CI: 7–17) at 2, 4, 6,
8, and 10 years respectively.
3.1.2. Epileptic syndromes
The risk of developing refractory epilepsy was higher in West
syndrome and in symptomatic generalized and symptomatic
partial groups, it was lower in idiopathic partial and idiopathic
generalized groups and it was intermediate in cryptogenic partial
Table 1
Risk of developing refractory epilepsy by epileptic syndrome.
Risk of developing refractory epilepsy (%) 95% CI
n 2 years 6 years 10 years
Idiopathic partiala 90 0% 1% (0–3) 1% (0–3)
Cryptogenic partial 54 4% (0–9) 9% (0–18) 9% (0–18)
Symptomatic partial 72 12% (7–19) 16% (8–24) 22% (10–34)
Idiopathic generalizedb 56 2% (0–5) 2% (0–5) 2% (0–5)
West syndrome 17 12% (0–27) 28% (4–52) 52% (10–94)
Symptomatic generalized 19 16% (0–32) 16% (0–32) 26%(2–50)
Epilepsies of undetermined
onsetc
29 3% (0–9) 3% (0–9) 12% (0–29)
Otherd 6 – – –
a Includes 17 benign infantile seizures, 52 benign rolandic epilepsies, 20 early-
onset benign childhood occipital epilepsy (Panayiotopoulos type) and 1 late-onset
childhood occipital epilepsy (Gastaut type).
b Includes 38 absence epilepsy (childhood and juvenile), 6 juvenile myoclonic
epilepsy, and 12 ‘‘other idiopathic generalized epilepsies’’.
c Includes 28 without unequivocal focal or generalized features and 1 with both
focal and generalized seizures.
d Other cryptogenic/symptomatic generalized.
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(Table 1).
3.1.3. Predictors of refractory epilepsy
Risk of developing refractory epilepsy was very low in
idiopathic epilepsy, it was high in remote symptomatic epilepsy
and it was intermediate in cryptogenic epilepsy. Risk of developing
refractory epilepsy at 2, 6 and 10 years was 1% (95% CI: 0–2), 2%
(95% CI: 0–2) and 2% (95% CI: 0–2) for idiopathic epilepsy, 3% (95%
CI: 0–7), 9% (95% CI: 2–16) and 9% (95% CI: 2–16) for cryptogenic
epilepsy, and 11% (95% CI: 5–17), 16% (95% CI: 9–23), and 28% (95%
CI: 16–40) for remote symptomatic epilepsy.
In univariable analysis, age at onset of epilepsy under 1 year,
remote symptomatic aetiology, global developmental delay/
mental retardation, abnormal neuroimaging, a multiple ﬁrst
seizure, West syndrome, more than one recurrence during the
ﬁrst 6 months after diagnosis and more than ﬁve seizures before
diagnosis, were all signiﬁcant predictors of a higher risk of
developing refractory epilepsy. Conversely, idiopathic aetiology
was a signiﬁcant predictor of a lower risk (Table 2).
In multivariable analysis with complete variable set, idiopathic
aetiology remained a signiﬁcant predictor of a lower risk of
developing refractory epilepsy and more than one recurrence
during the ﬁrst 6 months after diagnosis remained a signiﬁcantTable 2
Predictors of refractory epilepsy. Univariable and multivariable analyses. Cox proportio
n Univari
HR
Female sex 152 1.5
Age at onset <1 year 68 4.9
Idiopathic aetiology 146 0.1
Remote symptomatic aetiology 111 6.0
Global developmental delay/mental retardation 87 6.2
Motor deﬁcit 25 1.4
Abnormal neuroimaging 65 5.0
Abnormal EEG 216 1.5
Various seizure types 69 1.8
West syndrome 17 4.2
>1 seizures during the ﬁrst 6 months after diagnosis 116 7.2
First seizure as status 6 0.0
First seizure multiple 129 3.3
>5 seizures before treatment 124 4.4
Family history of seizures 29 0.3
Prior neonatal seizures 8 3.4
Prior febrile seizures 40 0.8predictor of a higher risk. Age at onset of epilepsy was almost
signiﬁcant (Table 2).
For more clinically relevant data, Table 3 shows the observed
risk of developing refractory epilepsy for patients with the three
more powerful predictive factors in multivariable analysis and
Table 4 shows the risk for patients with various combinations of
these factors.
4. Discussion
Prospective studies in children and adults with recent-onset
epilepsy have found a probability of achieving a 2-year initial
remission of 80–90% at 5–9 years.13–18 However, some patients
cannot be controlled adequately with antiepileptic medication
and develop refractory (intractable) epilepsy. The deﬁnition of
refractory epilepsy varies in different studies. Those studies on
children using stringent criteria, similar to those used in our study,
have found an incidence of refractory epilepsy between 6% and
14%.1,2,19,20 Early identiﬁcation of children at risk of developing
refractory epilepsy is important for parents’ counselling and
consideration of alternative treatments.
Anumberof studies investigatingpredictive factors for refractory
epilepsy in children were published. Most of these studies used
stringentdeﬁnitionsof refractory epilepsy, similar to the oneused in
our study.1–7 Two studies included less severe cases.8,9Most of these
studies have a case–control design. This type of study does not allow
estimation of the risk of developing refractory epilepsy in patients
with a given risk factor. Only three prospective cohort studies are
available.2,7,9 One of them did not include patients younger than 2
years old 7 (as discussed below, a group of children particularly at
risk of developing refractory epilepsy). Therefore, there was a need
for a population-based prospective cohort study.
Although our study is hospital-based, it has been designed to
obtain a sample as representative of general population as
possible. Most patients in Almerı´a with epileptic seizures are
cared for in Torrecardenas Hospital since it has the only paediatric
neurology unit in the province. Patients previously examined in
other centres were excluded. Consequently, our sample is based
exclusively on direct referrals by primary care paediatricians and
patients ﬁrst seen at the emergency department of our hospital.
The features of our sample are in accordance with those found in
epidemiological population-based studies of epilepsy.21–23 We
have focused on early predictors of refractory epilepsy andwe have
studied the prognostic value of those presentwithin 6months after
diagnosis of epilepsy.nal hazards model.
able Multivariable
95% CI p HR 95% CI p
0.7–3.0 0.296 2.1 0.9–4.6 0.070
2.4–10.1 0.000 2.6 1.0–6.9 0.051
0.0–0.4 0.001 0.2 0.0–0.8 0.030
2.7–13.4 0.000 1.0 0.2–7.2 0.967
2.9–13.3 0.000 1.9 0.4–9.4 0.412
0.4–4.9 0.523 0.4 0.1–1.5 0.172
2.4–10.2 0.000 1.3 0.4–4.0 0.693
0.7–3.4 0.314 0.7 0.3–1.9 0.507
0.8–4.0 0.134 2.3 0.9–5.6 0.073
1.6–11.0 0.003 0.9 0.3–3.3 0.932
3.1–17.0 0.000 4.8 1.8–13.0 0.002
– 0.620 0.0 – 0.982
1.6–7.1 0.002 1.2 0.5–3.0 0.751
2.0–9.6 0.000 2.4 0.8–7.0 0.113
0.0–2.6 0.301 0.2 0.0–2.2 0.208
0.8–14.5 0.091 0.8 0.2–3.7 0.750
0.2–2.7 0.735 1.4 0.3–6.0 0.643
Table 3
Risk of developing refractory epilepsy as a function of aetiology, age at onset of epilepsy and number of seizures during the ﬁrst 6 months after diagnosis. Kaplan–Meier
estimates.
n Risk of developing refractory epilepsy (%) (95% CI)
2 years 6 years 10 years
Idiopathic aetiology 146 1% (0–2%) 2% (0–2) 2% (0–2)
Non-idiopathic aetiology 197 9% (5–13) 13% (9–18) 20% (12–28)
Age at onset <1 year 68 12% (4–20) 20% (10–30) 33% (17–49)
Age at onset 1 year 275 3% (1–5) 5% (2–8) 7% (3–11)
>1 seizures during the ﬁrst 6 months after diagnosis 116 16% (9–23) 19% (12–26) 23% (14–32)
0–1 seizures during the ﬁrst 6 months after diagnosis 227 0% 2% (0–4) 7% (2–112)
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refractory epilepsy in previous studies have been the aetiology
and the age at onset of epilepsy. In all the aforementioned studies,
aetiology was a strong prognostic factor.1–9 All but one, which did
not include children younger than 2 years old7, found a higher risk
of refractory epilepsy in children with remote symptomatic
epilepsy. Six out of six studies found a higher risk related to the
presence of mental retardation and/or motor deﬁcit3–7,9 and three
out of three, a worse prognosis in children with abnormal
neuroimaging.2,5,6 In our univariable analysis, remote sympto-
matic aetiology, global developmental delay/mental retardation
and abnormal neuroimaging, signiﬁcantly increased the risk of
developing refractory epilepsy. The presence of motor deﬁcit
showed a non-signiﬁcant trend towards a higher risk. Conversely,
idiopathic aetiology was a signiﬁcant predictor of a lower risk of
refractory epilepsy. However, in multivariable analysis, idiopathic
aetiology was the only independent predictor of refractory
epilepsy among those related to aetiology. The risk of developing
refractory epilepsy at 6 years was 2% (95% CI: 0–2) in idiopathic
epilepsy compared to 13% (95% CI: 9–18) in non-idiopathic
epilepsy.
The second factor strongly correlated in the literature with the
risk of developing refractoriness is the age at onset of epilepsy. All
but two of the previous studies7,9 found a greater risk of refractory
epilepsy in younger children, particularly in those younger than 1
year old. In one of these two studies, only patients older than two
were enrolled.7 The association remained inmultivariable analysis
in most of these studies. In our study, children aged under 1 at the
onset of epilepsy showed a signiﬁcant association with a greater
risk of refractory epilepsy in univariable analysis and an almost
signiﬁcant tendency towards a greater risk in multivariable
analysis. Risk of refractory epilepsy at 6 years was 20% (95% CI:
10–30) in children younger than 1 compared with 5% (95% CI: 2–8)
in older children.
Three out of three studies found a higher risk of refractory
epilepsy in patients with recurrences after beginning antiepilepticTable 4
Observed risk of developing refractory epilepsy in patients with various
combinations of predictive factors. Kaplan–Meier estimates. 95% CI: 95% conﬁdence
interval. Seizures 6 months: seizures during the ﬁrst 6 month after diagnosis.
n Risk of developing refractory epilepsy (%)
(95% CI)
2 years 6 years 10 years
Idiopathic aetiology 146 1% (0–2) 2% (0–2) 2% (0–2)
Non-idiopathic aetiology
Age at onset <1 year
>1 seizures 6 months 29 28% (12–44) 38% (20–56) 49%(25–73)
0–1 seizures 6 months 25 0% 9% (0–21) 27% (3–51)
Age at onset 1 year
>1 seizures 6 months 38 18% (6–30) 22% (9–35) 30% (11–49)
0–1 seizures 6 months 105 0% 3% (0–7) 5% (0–11)treatment, although the variables measured were different: a high
initial frequency of seizures9, three or more seizures in the second
6months of treatment6 and seizure recurrence in the interval from
sixth to twelfth months after initiating therapy.7 In a previous
study carried out by our group, which involved a different sample,
recurrence of seizures in the ﬁrst 6 months of treatment
diminished the probability of achieving a 2-year initial remission
and a 3-year terminal remissionwithout treatment.17,24 In our new
study, the risk of developing refractory epilepsy was 19% (95% CI:
12–26) at 6 years in children with more than one recurrence in the
ﬁrst 6 months after diagnosis compared to 2% (95% CI: 0–4) in
those with only one or no recurrences. This association was
signiﬁcant in univariable and multivariable analyses.
In the present study, a simple model comprising three
variables (aetiology, age at onset of epilepsy and number of
seizures during the ﬁrst 6 months after diagnosis) classiﬁed
epileptic patients in groups with low, intermediate and high risk
of refractory epilepsy.
The value of other potential predictive factors is less
established. Five out of six previous studies found, in univariable
analysis, a higher risk of refractory epilepsy in patients with
West syndrome or infantile spasms.1,4,6,9 In two, the association
remained in multivariable analysis.1,4 Similarly, in our study the
association was signiﬁcant in the univariable but not in the
multivariable analysis.
Some authors2,3,6 but not all7,9 found a greater risk of refractory
epilepsy in patients with a high number of pre-treatment seizures.
In none of these studies the association was signiﬁcant in
multivariable analysis. In our study, this factor was signiﬁcant
only in univariable analysis, although there was also a clear trend
in multivariable analysis.
A signiﬁcant proportion of studies available observed a greater
risk of refractory epilepsy in patients with prior neonatal
seizures1,2,4,6,8 but only in univariable analysis. In our cohort,
we observed a clear but non-signiﬁcant tendency towards a higher
risk of refractory epilepsy in this situation, but we found it only in
univariable analysis.
A history of status epilepticus has also been frequently
associated with a worse prognosis.1–3,5,6,8,9 This was not observed
in our sample. Nevertheless, we have found a greater risk of
refractory epilepsy in patients with a multiple ﬁrst seizure, but
solely in univariable analysis. One previous study has investigated
this question and made similar ﬁndings.2
The ﬁndings about the predictive value of the EEG are
discordant, regarding whether there is an association or not and
in relation to the type of abnormality with prognostic value.2,3,5–8
We have found no relationship between an abnormal EEG during
the ﬁrst 6 months after diagnosis and the risk of refractory
epilepsy.
Finally, we have not found any predictive value for the presence
of prior febrile seizures. Only one out of nine previous studies
found a signiﬁcant relationship between this factor and the risk of
refractoriness.
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of developing refractory epilepsy was higher in West syndrome
and in symptomatic generalized and symptomatic partial groups;
it is lower in idiopathic partial and idiopathic generalized groups
and intermediate in cryptogenic partial epilepsies and in epilepsies
without unequivocal focal or generalized seizures. One prospective
study reported similar ﬁndings.2 Although some conﬁdence
intervals are wide, we have found some estimations of clinical
relevance: the risk of refractory epilepsy at 6 years was 1% (95% CI:
0–3) in idiopathic partial epilepsies, 2% (95% CI: 0–5) in idiopathic
generalized epilepsies and 9% (95% CI: 8–24) in cryptogenic partial
epilepsies.
In conclusion, syndromic diagnosis and a few prognostic factors
are valuable for the early prediction of refractory epilepsy in
children. Both approaches are complementary. Most speciﬁc
syndromes encountered in daily practice are idiopathic and they
have an excellent prognosis. Most of the rest of patients are
classiﬁed in non-speciﬁc categories and their prognosis may be
reﬁned using the additional prognostic factors.
Conﬂict of interest
None.
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